Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer now shows Revision: v3.6.6, indicating a minor version update to the page rather than any content changes.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page footer revision tag has been updated from v3.6.4 to v3.6.5, indicating a platform version update. This change does not alter the study details or content presented on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now displays Revision: v3.6.4 instead of v3.6.3, indicating a newer page version. No study information or user-facing functionality appears to be affected.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page footer, indicating a new deployment version. This reflects an internal update tag rather than a change to the study content or presented data.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer page build that may include minor fixes or UI refinements without changing the study information.SummaryDifference0.0%

- Check91 days agoChange DetectedNew help and guidance sections were added to assist users in reading the study record and joining the study, and the Intervention/Treatment label was standardized. The recruitment status was updated to indicate no longer looking for participants, and the page revision tag was updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.